Cassava Sciences (PTIE) –
-
Form 8-K CASSAVA SCIENCES INC For: Mar 27
-
Pain Therapeutics (PTIE) Announces Name Change to Cassava Sciences (SAVA)
-
Pain Therapeutics Announces Name Change to Cassava Sciences, Inc.
-
Pain Therapeutics Announces Name Change to Cassava Sciences, Inc.
-
Form 8-K PAIN THERAPEUTICS INC For: Mar 25
-
Pain Therapeutics Reports 2018 Financial Results and Corporate Update
-
Pain Therapeutics Reports 2018 Financial Results and Corporate Update
-
Form 8-K PAIN THERAPEUTICS INC For: Mar 22
-
Form SC 13G PAIN THERAPEUTICS INC Filed by: HIRSCHMAN ORIN
-
Form SC 13G/A PAIN THERAPEUTICS INC Filed by: ARMISTICE CAPITAL, LLC
-
Form SC 13G/A PAIN THERAPEUTICS INC Filed by: CVI Investments, Inc.
-
Form SC 13G/A PAIN THERAPEUTICS INC Filed by: SATTERFIELD THOMAS A JR
-
Form SC 13G/A PAIN THERAPEUTICS INC Filed by: First Eagle Investment Management, LLC
-
Form 8-K PAIN THERAPEUTICS INC For: Feb 08
-
Form SC 13G/A PAIN THERAPEUTICS INC Filed by: INTRACOASTAL CAPITAL, LLC
-
Form SC 13G/A PAIN THERAPEUTICS INC Filed by: PAIN THERAPEUTICS INC
-
Form SC 13G PAIN THERAPEUTICS INC Filed by: Hudson Bay Capital Management LP
-
Pain Therapeutics (PTIE) says FDA denies making math errors, material mistakes or misrepresentations during June Advisory Committee Meeting for REMOXY
-
Pain Therapeutics Announces Feedback from Recent Meeting with FDA on REMOXY
-
Pain Therapeutics Announces Feedback from Recent Meeting with FDA on REMOXY
-
Form EFFECT PAIN THERAPEUTICS INC
-
Pain Therapeutics Announces Academic Collaboration with The University of Texas at Austin
-
Pain Therapeutics Announces Academic Collaboration with The University of Texas at Austin
-
Pain Therapeutics (PTIE) Secures $1.5M Research Grant by National Institutes of Health
-
Pain Therapeutics Awarded $1.5 Million Research Grant by National Institutes of Health
-
Pain Therapeutics Awarded $1.5 Million Research Grant by National Institutes of Health
-
Pain Therapeutics (PTIE) Reports Publication of Two New Peer-Reviewed Studies for REMOXY ER (extended-release oxycodone)
-
Pain Therapeutics Announces Two New Peer-Reviewed Publications for REMOXY
-
Pain Therapeutics Announces Two New Peer-Reviewed Publications for REMOXY
-
Pain Therapeutics Announces Filing of Registration Statement on SEC Form S-1
-
Pain Therapeutics Announces Filing of Registration Statement on SEC Form S-1
-
Form S-1 PAIN THERAPEUTICS INC
-
Form SC 13G/A PAIN THERAPEUTICS INC Filed by: Nantahala Capital Management, LLC
-
Pain Therapeutics (PTIE) Reports Commencement of Phase II Study in Alzheimer’s Disease
-
Pain Therapeutics Announces Initiation of a Phase II Study in Alzheimer’s Disease
-
Pain Therapeutics Announces Initiation of a Phase II Study in Alzheimer’s Disease
-
Pain Therapeutics (PTIE) Appeals FDA Decision on REMOXY
-
Pain Therapeutics Appeals FDA Decision on REMOXY
-
Pain Therapeutics Appeals FDA Decision on REMOXY
-
Form 4 PAIN THERAPEUTICS INC For: Oct 31 Filed by: Schoen Eric
-
Form 3 PAIN THERAPEUTICS INC For: Oct 31 Filed by: Schoen Eric
-
Form 10-Q PAIN THERAPEUTICS INC For: Sep 30
-
Form 8-K PAIN THERAPEUTICS INC For: Oct 29
-
Pain Therapeutics Reports Third Quarter 2018 Financial Results
-
Pain Therapeutics Reports Third Quarter 2018 Financial Results
-
Pain Therapeutics Invites you to Join a Conference Call on Third Quarter 2018 Financial Results
-
Pain Therapeutics Invites you to Join a Conference Call on Third Quarter 2018 Financial Results
-
New Research Coverage Highlights Adesto Technologies, Pain Therapeutics, U.S. Global Investors, GTx, Columbus McKinnon, and Baytex Energy — Consolidated Revenues, Company Growth, and Expectations fo
-
Form 8-K PAIN THERAPEUTICS INC For: Oct 11
-
Pain Therapeutics (PTIE) Reports Appointment of Eric Schoen as Chief Financial Officer
Back to PTIE Stock Lookup
